Table 7.
Global photodamage score value changes
| BG11001 |
Placebo |
p1) | p2) | ||
|---|---|---|---|---|---|
| Arbitrary units (Average ± SD) | |||||
| GPDS | Baseline | 3.31 ± 1.15 | 3.44 ± 1.25 | 0.639 | |
| After 8 wk | 3.15 ± 1.04 | 3.41 ± 1.21 | 0.318 | 0.262 | |
| Difference3) | −0.15 ± 0.75 | −0.03 ± 0.54 | 0.386 | ||
| p4) | 0.205 | 0.767 | |||
| After 16 wk | 3.13 ± 1.01 | 3.33 ± 1.13 | 0.400 | 0.397 | |
| Difference5) | −0.18 ± 0.64 | −0.10 ± 0.60 | 0.586 | ||
| p4) | 0.026∗ | 0.016∗ | |||
| After 24 wk | 3.05 ± 1.03 | 3.38 ± 1.14 | 0.178 | 0.062 | |
| Difference6) | −0.26 ± 0.60 | −0.05 ± 0.61 | 0.135 | ||
| p4) | 0.010∗ | 0.599 | |||
∗p < 0.05 by Student t-test for comparison with placebo group.
∗∗p < 0.01 by Student t-test for comparison with placebo group.
Compared between groups: p by Student t-test.
Compared between groups: p by analysis of covariance (adjustment with baseline).
After 8 wk – baseline.
Compared within groups: p by paired t-test.
After 16 wk – baseline.
After 24 wk – baseline.